Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07782775 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT07782775 · ClinicalTrials.gov record · last posted 2026-08-24

A Study to Assess the Bioequivalence of Efgartigimod PH20 SC Between Autoinjector and Prefilled Syringe in Healthy Adult Participants

Name: A Study to Assess the Bioequivalence of Efgartigimod PH20 SC Between Autoinjector and Prefilled Syringe in Healthy Adult Participants — clinical trial record (NCT07782775)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1

Sponsorargenx

Started2026-06-19

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The aim of this study is to compare the amount of efgartigimod in the blood over time after it is injected via Prefilled syringe (PFS) and Autoinjector (AI). The study will comprise 2 study periods of 3 weeks each. Each participant receives both efgartigimod PH20 SC AI and PFS treatments, in a different order. Participants will be in the study for up to approximately 9 weeks.

Trial Details

NCT Number	NCT07782775
Lead Sponsor	argenx
Conditions	Healthy Volunteer, Healthy Adult Participants
Enrollment	32 participants
Start Date	2026-06-19
Primary Completion	2026-09-18 (estimated)
Study Completion	2026-09-18 (estimated)
Updated on ClinicalTrials.gov	2026-08-24